U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H19NOS
Molecular Weight 297.4163
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DULOXETINE

SMILES

CNCC[C@@]([H])(c1cccs1)Oc2cccc3ccccc32

InChI

InChIKey=ZEUITGRIYCTCEM-KRWDZBQOSA-N
InChI=1S/C18H19NOS/c1-19-12-11-17(18-10-5-13-21-18)20-16-9-4-7-14-6-2-3-8-15(14)16/h2-10,13,17,19H,11-12H2,1H3/t17-/m0/s1

HIDE SMILES / InChI

Description
Curator's Comment:: Description was created based on several sources, including https://www.drugs.com/pro/cymbalta.html

Duloxetine (brand names Cymbalta, Yentreve, and in parts of Europe, Xeristar or Ariclaim) is indicated for the acute and maintenance treatment of major depressive disorder (MDD), as well as acute management of generalized anxiety disorder. Also used for the management of neuropathic pain associated with diabetic peripheral neuropathy, and fibromyalgia. Has been used in the management of moderate to severe stress urinary incontinence (SUI) in women. It is manufactured and marketed by Eli Lilly and Company. Duloxetine has not yet been FDA approved for stress urinary incontinence or for fibromyalgia. Duloxetine is a selective SNRI (selective serotonin-norepinephrine reuptake inhibitor). Duloxetine is a systemic drug therapy which affects the body as a whole. Known also under the code name LY248686, it is a potent dual reuptake inhibitor of serotonin (5-hydroxytryptamine, 5-HT) and norepinephrine (NE), possessing comparable affinities in binding to NE- and 5-HT transporter sites. It is a less potent inhibitor of dopamine reuptake.

Originator

Curator's Comment:: # Eli Lilly

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
10.4 nM [IC50]
1.58 nM [IC50]
142.8 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Cymbalta

Approved Use

Cymbalta® is indicated for the treatment of: Major Depressive Disorder Generalized Anxiety Disorder Diabetic Peripheral Neuropathy Fibromyalgia Chronic Musculoskeletal Pain

Launch Date

1.09140482E12
Primary
Cymbalta

Approved Use

Cymbalta® is indicated for the treatment of: Major Depressive Disorder Generalized Anxiety Disorder Diabetic Peripheral Neuropathy Fibromyalgia Chronic Musculoskeletal Pain

Launch Date

1.09140482E12
Palliative
Cymbalta

Approved Use

Cymbalta® is indicated for the treatment of: Major Depressive Disorder Generalized Anxiety Disorder Diabetic Peripheral Neuropathy Fibromyalgia Chronic Musculoskeletal Pain

Launch Date

1.09140482E12
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
55.88 μg/L
60 mg single, oral
dose: 60 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DULOXETINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: FASTED
0.44 μg/L
15 mg single, oral
dose: 15 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DULOXETINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: FASTED
31.82 μg/L
30 mg single, oral
dose: 30 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DULOXETINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: FASTED
43.09 μg/L
30 mg 1 times / day multiple, oral
dose: 30 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
DULOXETINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: FASTED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
1073.99 μg × h/L
60 mg single, oral
dose: 60 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DULOXETINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: FASTED
175.39 μg × h/L
15 mg single, oral
dose: 15 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DULOXETINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: FASTED
489.35 μg × h/L
30 mg single, oral
dose: 30 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DULOXETINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: FASTED
840.26 μg × h/L
30 mg 1 times / day multiple, oral
dose: 30 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
DULOXETINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: FASTED
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
11.89 h
60 mg single, oral
dose: 60 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DULOXETINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: FASTED
9.52 h
15 mg single, oral
dose: 15 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DULOXETINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: FASTED
10.19 h
30 mg single, oral
dose: 30 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
DULOXETINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: FASTED
11.39 h
30 mg 1 times / day multiple, oral
dose: 30 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
DULOXETINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: FASTED
Funbound

Funbound

ValueDoseCo-administeredAnalytePopulation
10%
DULOXETINE plasma
Homo sapiens
population: UNKNOWN
age: UNKNOWN
sex: UNKNOWN
food status: UNKNOWN
Doses

Doses

DosePopulationAdverse events​
60 mg 2 times / day multiple, oral (max)
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy, 17 - 89
n = 2327
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: 17 - 89
Sex: M+F
Population Size: 2327
Sources:
Disc. AE: Nausea...
60 mg 2 times / day multiple, oral (max)
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy, 17 - 89
n = 568
Health Status: unhealthy
Condition: Diabetic Peripheral Neuropathic Pain
Age Group: 17 - 89
Sex: M+F
Population Size: 568
Sources:
Disc. AE: Nausea, Dizziness...
AEs leading to
discontinuation/dose reduction:
Nausea (3.5%)
Dizziness (1.6%)
Somnolence (1.6%)
Fatigue (1.1%)
Sources:
60 mg 2 times / day multiple, oral (max)
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy, 17 - 89
n = 668
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Age Group: 17 - 89
Sex: M+F
Population Size: 668
Sources:
Disc. AE: Nausea, Vomiting...
AEs leading to
discontinuation/dose reduction:
Nausea (3.7%)
Vomiting (1.3%)
Dizziness (1%)
Sources:
60 mg 2 times / day multiple, oral (max)
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy, 17 - 89
n = 876
Health Status: unhealthy
Condition: Fibromyalgia
Age Group: 17 - 89
Sex: M+F
Population Size: 876
Sources:
Disc. AE: Nausea, Somnolence...
AEs leading to
discontinuation/dose reduction:
Nausea (1.9%)
Somnolence (1.5%)
Fatigue (1.3%)
Sources:
2820 mg single, oral
Overdose
Dose: 2820 mg
Route: oral
Route: single
Dose: 2820 mg
Sources:
unhealthy, 25
n = 1
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: 25
Sex: M
Population Size: 1
Sources:
Disc. AE: Generalized tonic-clonic seizure, Blurred vision...
AEs leading to
discontinuation/dose reduction:
Generalized tonic-clonic seizure
Blurred vision
Irritability
Anxiety
Sources:
120 mg 1 times / day multiple, oral
Recommended
Dose: 120 mg, 1 times / day
Route: oral
Route: multiple
Dose: 120 mg, 1 times / day
Sources: Page: p.459
unhealthy, 49.9
n = 82
Health Status: unhealthy
Condition: Fibromyalgia
Age Group: 49.9
Sex: M+F
Population Size: 82
Sources: Page: p.459
Disc. AE: Dizziness, Pain...
AEs leading to
discontinuation/dose reduction:
Dizziness (3%)
Pain (3%)
Sources: Page: p.459
120 mg 1 times / day multiple, oral
Recommended
Dose: 120 mg, 1 times / day
Route: oral
Route: multiple
Dose: 120 mg, 1 times / day
Sources: Page: p.458
unhealthy, 51.5
n = 72
Health Status: unhealthy
Condition: Fibromyalgia
Age Group: 51.5
Sex: M+F
Population Size: 72
Sources: Page: p.458
Disc. AE: Fatigue, Insomnia...
AEs leading to
discontinuation/dose reduction:
Fatigue (4%)
Insomnia (4%)
Sources: Page: p.458
4 mg single, oral
Dose: 4 mg
Route: oral
Route: single
Dose: 4 mg
Sources:
healthy, adult
n = 83
Health Status: healthy
Age Group: adult
Sex: M
Population Size: 83
Sources:
Other AEs: Fatigue, Nausea...
Other AEs:
Fatigue (below serious, 2 patients)
Nausea (below serious, 2 patients)
Libido decreased (below serious, 1 patient)
Stomach discomfort (below serious, 4 patients)
Sources:
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy, children|adolescents
n = 117
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: children|adolescents
Population Size: 117
Sources:
Other AEs: Syncope, Drug abuse...
Other AEs:
Syncope (serious, 1 patient)
Drug abuse (serious, 1 patient)
Panic attack (serious, 1 patient)
Social phobia (serious, 1 patient)
Diarrhoea (below serious, 6 patients)
Nausea (below serious, 20 patients)
Vomiting (below serious, 7 patients)
Fatigue (below serious, 8 patients)
Influenza (below serious, 7 patients)
Upper respiratory tract infection (below serious, 4 patients)
Decreased appetite (below serious, 10 patients)
Dizziness (below serious, 10 patients)
Headache (below serious, 19 patients)
Somnolence (below serious, 7 patients)
Insomnia (below serious, 6 patients)
Sources:
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy, elderly
n = 151
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: elderly
Population Size: 151
Sources:
Other AEs: Constipation, Diarrhoea...
Other AEs:
Constipation (below serious, 21 patient)
Diarrhoea (below serious, 14 patients)
Dry mouth (below serious, 33 patients)
Nausea (below serious, 50 patients)
Fatigue (below serious, 16 patients)
Decreased appetite (below serious, 8 patients)
Dizziness (below serious, 14 patients)
Somnolence (below serious, 16 patients)
Hyperhidrosis (below serious, 16 patients)
Sources:
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy, elderly
n = 51
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: elderly
Population Size: 51
Sources:
Other AEs: Prostate cancer, Ejaculation delayed...
Other AEs:
Prostate cancer (serious, 1 patient)
Ejaculation delayed (below serious, 3 patients)
Erectile dysfunction (below serious, 3 patients)
Sources:
60 mg 2 times / day multiple, oral
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy
Health Status: unhealthy
Condition: Major Depressive Disorder|Generalized Anxiety Disorder
Sources:
Disc. AE: Suicidal ideation, Suicidal behavior...
AEs leading to
discontinuation/dose reduction:
Suicidal ideation
Suicidal behavior
Hepatic failure
Orthostatic hypotension
Syncope
Serotonin syndrome
Neuroleptic malignant syndrome
Bleeding
Mania
Hypomania
Seizures
Hyponatremia
Urinary hesitation
Urinary retention
Sources:
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Other AEs: Myocardial infarction, Diarrhoea...
Other AEs:
Myocardial infarction (serious, 1 patient)
Diarrhoea (serious, 1 patient)
Hypoaesthesia oral (serious, 1 patient)
Hypoaesthesia (serious, 1 patient)
Transient ischaemic attack (serious, 1 patient)
Palpitations (below serious, 3 patients)
Vision blurred (below serious, 2 patients)
Abdominal distension (below serious, 2 patients)
Abdominal pain (below serious, 1 patient)
Abdominal pain upper (below serious, 2 patients)
Constipation (below serious, 14 patients)
Diarrhoea (below serious, 7 patients)
Dry mouth (below serious, 12 patients)
Dyspepsia (below serious, 3 patients)
Gastrooesophageal reflux disease (below serious, 2 patients)
Nausea (below serious, 14 patients)
Stomach discomfort (below serious, 2 patients)
Vomiting (below serious, 3 patients)
Asthenia (below serious, 3 patients)
Fatigue (below serious, 10 patients)
Irritability (below serious, 2 patients)
Therapeutic response unexpected (below serious, 1 patient)
Urinary tract infection (below serious, 2 patients)
Anorexia (below serious, 3 patients)
Decreased appetite (below serious, 5 patients)
Hyperglycaemia (below serious, 1 patient)
Hypokalaemia (below serious, 2 patients)
Muscle spasms (below serious, 1 patient)
Musculoskeletal pain (below serious, 2 patients)
Pain in extremity (below serious, 2 patients)
Dizziness (below serious, 9 patients)
Headache (below serious, 10 patients)
Hypersomnia (below serious, 1 patient)
Hypoaesthesia (below serious, 1 patient)
Lethargy (below serious, 2 patients)
Paraesthesia (below serious, 2 patients)
Sedation (below serious, 3 patients)
Somnolence (below serious, 14 patients)
Anorgasmia (below serious, 3 patients)
Insomnia (below serious, 21 patient)
Libido decreased (below serious, 4 patients)
Loss of libido (below serious, 2 patients)
Sleep disorder (below serious, 4 patients)
Nocturia (below serious, 4 patients)
Pollakiuria (below serious, 2 patients)
Ejaculation delayed (below serious, 2 patients)
Ejaculation disorder (below serious, 2 patients)
Erectile dysfunction (below serious, 3 patients)
Testicular pain (below serious, 2 patients)
Pharyngolaryngeal pain (below serious, 2 patients)
Yawning (below serious, 1 patient)
Hyperhidrosis (below serious, 5 patients)
Pruritus (below serious, 3 patients)
Hot flush (below serious, 1 patient)
Hypertension (below serious, 5 patients)
Sources:
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Other AEs: Wrist fracture, Osteoarthritis...
Other AEs:
Wrist fracture (serious, 1 patient)
Osteoarthritis (serious, 2 patients)
Encephalopathy hypertensive (serious, 1 patient)
Transient ischaemic attack (serious, 1 patient)
Tachycardia (below serious, 3 patients)
Vertigo (below serious, 3 patients)
Abdominal distension (below serious, 3 patients)
Abdominal pain upper (below serious, 2 patients)
Constipation (below serious, 6 patients)
Diarrhoea (below serious, 8 patients)
Dry mouth (below serious, 11 patient)
Dyspepsia (below serious, 2 patients)
Nausea (below serious, 14 patients)
Vomiting (below serious, 2 patients)
Asthenia (below serious, 2 patients)
Fatigue (below serious, 8 patients)
Influenza (below serious, 4 patients)
Sinusitis (below serious, 2 patients)
Weight increased (below serious, 2 patients)
Anorexia (below serious, 2 patients)
Neck pain (below serious, 3 patients)
Dizziness (below serious, 7 patients)
Dysgeusia (below serious, 2 patients)
Migraine (below serious, 3 patients)
Somnolence (below serious, 6 patients)
Erectile dysfunction (below serious, 3 patients)
Hyperhidrosis (below serious, 8 patients)
Sources:
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 20
Health Status: unhealthy
Condition: Depression
Population Size: 20
Sources:
Other AEs: Gastrointestinal disorder (NOS), Sinus infection...
Other AEs:
Gastrointestinal disorder (NOS) (serious, 1 patient)
Sinus infection (serious, 1 patient)
Nausea (below serious, 9 patients)
Dry mouth (below serious, 7 patients)
Constipation (below serious, 5 patients)
Hyperhidrosis (below serious, 5 patients)
Sources:
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 263
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 263
Sources:
Other AEs: Intervertebral disc protrusion, Constipation...
Other AEs:
Intervertebral disc protrusion (serious, 1 patient)
Constipation (below serious, 35 patients)
Diarrhoea (below serious, 27 patients)
Dry mouth (below serious, 31 patient)
Nausea (below serious, 83 patients)
Vomiting (below serious, 12 patients)
Fatigue (below serious, 25 patients)
Decreased appetite (below serious, 13 patients)
Dizziness (below serious, 26 patients)
Headache (below serious, 45 patients)
Somnolence (below serious, 15 patients)
Insomnia (below serious, 24 patients)
Hyperhidrosis (below serious, 23 patients)
Hot flush (below serious, 13 patients)
Sources:
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Other AEs: Acute myocardial infarction, Vertigo...
Other AEs:
Acute myocardial infarction (serious, 1 patient)
Vertigo (serious, 1 patient)
Alcohol poisoning (serious, 1 patient)
Myopathy toxic (serious, 1 patient)
Asthma (serious, 1 patient)
Tinnitus (below serious, 2 patients)
Vertigo (below serious, 5 patients)
Vision blurred (below serious, 2 patients)
Constipation (below serious, 12 patients)
Diarrhoea (below serious, 9 patients)
Dry mouth (below serious, 13 patients)
Flatulence (below serious, 3 patients)
Nausea (below serious, 35 patients)
Toothache (below serious, 2 patients)
Asthenia (below serious, 2 patients)
Fatigue (below serious, 7 patients)
Hypertransaminasaemia (below serious, 2 patients)
Nasopharyngitis (below serious, 5 patients)
Viral infection (below serious, 2 patients)
Joint sprain (below serious, 2 patients)
Anorexia (below serious, 4 patients)
Decreased appetite (below serious, 2 patients)
Increased appetite (below serious, 2 patients)
Muscle spasms (below serious, 2 patients)
Neck pain (below serious, 2 patients)
Dizziness (below serious, 10 patients)
Headache (below serious, 27 patients)
Migraine (below serious, 2 patients)
Somnolence (below serious, 10 patients)
Confusional state (below serious, 2 patients)
Libido decreased (below serious, 4 patients)
Urinary retention (below serious, 2 patients)
Urine flow decreased (below serious, 2 patients)
Ejaculation disorder (below serious, 2 patients)
Sexual dysfunction (below serious, 2 patients)
Yawning (below serious, 4 patients)
Hyperhidrosis (below serious, 5 patients)
Pruritus (below serious, 2 patients)
Sources:
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 108
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 108
Sources:
Other AEs: Palpitations, Vision blurred...
Other AEs:
Palpitations (below serious, 3 patients)
Vision blurred (below serious, 3 patients)
Abdominal discomfort (below serious, 7 patients)
Constipation (below serious, 10 patients)
Dry mouth (below serious, 10 patients)
Nausea (below serious, 30 patients)
Vomiting (below serious, 6 patients)
Asthenia (below serious, 5 patients)
Fatigue (below serious, 4 patients)
Anorexia (below serious, 6 patients)
Decreased appetite (below serious, 3 patients)
Dizziness (below serious, 15 patients)
Somnolence (below serious, 12 patients)
Tremor (below serious, 4 patients)
Hyperhidrosis (below serious, 7 patients)
Sources:
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Other AEs: Coronary artery disease, Urosepsis...
Other AEs:
Coronary artery disease (serious, 1 patient)
Urosepsis (serious, 1 patient)
Fall (serious, 1 patient)
Metastases to central nervous system (serious, 1 patient)
Syncope (serious, 1 patient)
Palpitations (below serious, 4 patients)
Vision blurred (below serious, 5 patients)
Abdominal discomfort (below serious, 5 patients)
Abdominal pain (below serious, 4 patients)
Abdominal pain upper (below serious, 7 patients)
Constipation (below serious, 23 patients)
Diarrhoea (below serious, 18 patients)
Dry mouth (below serious, 25 patients)
Dyspepsia (below serious, 3 patients)
Flatulence (below serious, 6 patients)
Nausea (below serious, 41 patient)
Vomiting (below serious, 11 patient)
Fatigue (below serious, 18 patients)
Feeling jittery (below serious, 3 patients)
Thirst (below serious, 3 patients)
Liver function test abnormal (below serious, 3 patients)
Weight increased (below serious, 3 patients)
Decreased appetite (below serious, 15 patients)
Arthralgia (below serious, 6 patients)
Dizziness (below serious, 17 patients)
Dysgeusia (below serious, 4 patients)
Headache (below serious, 16 patients)
Somnolence (below serious, 14 patients)
Tremor (below serious, 3 patients)
Insomnia (below serious, 13 patients)
Libido decreased (below serious, 5 patients)
Dysuria (below serious, 3 patients)
Pollakiuria (below serious, 6 patients)
Urine flow decreased (below serious, 3 patients)
Erectile dysfunction (below serious, 5 patients)
Cough (below serious, 6 patients)
Dermatitis contact (below serious, 3 patients)
Hyperhidrosis (below serious, 10 patients)
Night sweats (below serious, 4 patients)
Rash (below serious, 3 patients)
Hot flush (below serious, 4 patients)
Hypertension (below serious, 3 patients)
Sources:
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Other AEs: Non-cardiac chest pain, Conjunctivitis...
Other AEs:
Non-cardiac chest pain (serious, 1 patient)
Conjunctivitis (below serious, 2 patients)
Vision blurred (below serious, 1 patient)
Abdominal pain (below serious, 1 patient)
Colonic polyp (below serious, 1 patient)
Constipation (below serious, 2 patients)
Dry mouth (below serious, 3 patients)
Gastritis (below serious, 1 patient)
Nausea (below serious, 11 patient)
Stomach discomfort (below serious, 1 patient)
Vomiting (below serious, 2 patients)
Irritability (below serious, 2 patients)
Non-cardiac chest pain (below serious, 1 patient)
Therapeutic response unexpected (below serious, 1 patient)
Drug hypersensitivity (below serious, 1 patient)
Cystitis (below serious, 1 patient)
Folliculitis (below serious, 1 patient)
Gastroenteritis (below serious, 1 patient)
Kidney infection (below serious, 1 patient)
Pharyngitis (below serious, 4 patients)
Tooth abscess (below serious, 1 patient)
Urinary tract infection (below serious, 2 patients)
Joint injury (below serious, 1 patient)
Muscle strain (below serious, 1 patient)
Neurological examination abnormal (below serious, 1 patient)
Anorexia (below serious, 1 patient)
Dehydration (below serious, 1 patient)
Hyperglycaemia (below serious, 1 patient)
Arthralgia (below serious, 2 patients)
Back pain (below serious, 1 patient)
Groin pain (below serious, 1 patient)
Haemarthrosis (below serious, 1 patient)
Muscle spasms (below serious, 1 patient)
Musculoskeletal pain (below serious, 1 patient)
Myalgia (below serious, 1 patient)
Osteoarthritis (below serious, 1 patient)
Aphonia (below serious, 1 patient)
Dizziness (below serious, 3 patients)
Hypersomnia (below serious, 1 patient)
Somnolence (below serious, 3 patients)
Confusional state (below serious, 1 patient)
Dysphoria (below serious, 1 patient)
Insomnia (below serious, 6 patients)
Libido decreased (below serious, 2 patients)
Breast cyst (below serious, 1 patient)
Erectile dysfunction (below serious, 1 patient)
Haemorrhage vaginal (below serious, 1 patient)
Vulvovaginal pruritus (below serious, 1 patient)
Asthma (below serious, 2 patients)
Epistaxis (below serious, 1 patient)
Nasal congestion (below serious, 1 patient)
Acne (below serious, 1 patient)
Generalised pruritus (below serious, 1 patient)
Psoriasis (below serious, 1 patient)
Cardiac ablation (below serious, 1 patient)
Sources:
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Other AEs: Arrhythmia, Atrial flutter...
Other AEs:
Arrhythmia (serious, 1 patient)
Atrial flutter (serious, 1 patient)
Coronary artery occlusion (serious, 1 patient)
Pneumoperitoneum (serious, 1 patient)
Chest pain (serious, 2 patients)
Abscess intestinal (serious, 1 patient)
Ankle fracture (serious, 1 patient)
Head injury (serious, 1 patient)
Hip fracture (serious, 1 patient)
Diabetes mellitus (serious, 1 patient)
Osteoarthritis spinal (serious, 1 patient)
Oesophageal adenocarcinoma metastatic (serious, 1 patient)
Intracranial aneurysm (serious, 1 patient)
Renal failure acute (serious, 1 patient)
Prostatitis (serious, 1 patient)
Dyspnoea (serious, 1 patient)
Interstitial lung disease (serious, 1 patient)
Orthostatic hypotension (serious, 1 patient)
Constipation (below serious, 37 patients)
Diarrhoea (below serious, 31 patient)
Dry mouth (below serious, 34 patients)
Nausea (below serious, 28 patients)
Fatigue (below serious, 14 patients)
Upper respiratory tract infection (below serious, 13 patients)
Contusion (below serious, 12 patients)
Fall (below serious, 59 patients)
Pain in extremity (below serious, 10 patients)
Dizziness (below serious, 26 patients)
Headache (below serious, 32 patients)
Hyperhidrosis (below serious, 15 patients)
Orthostatic hypotension (below serious, 5 patients)
Sources:
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Other AEs: Muscular weakness, Dizziness...
Other AEs:
Muscular weakness (serious, 1 patient)
Dizziness (serious, 1 patient)
Dyspnoea (serious, 1 patient)
Palpitations (below serious, 3 patients)
Vision blurred (below serious, 1 patient)
Abdominal pain (below serious, 2 patients)
Constipation (below serious, 10 patients)
Diarrhoea (below serious, 10 patients)
Dry mouth (below serious, 12 patients)
Dyspepsia (below serious, 3 patients)
Nausea (below serious, 24 patients)
Vomiting (below serious, 2 patients)
Fatigue (below serious, 7 patients)
Feeling abnormal (below serious, 2 patients)
Gastroenteritis (below serious, 3 patients)
Influenza (below serious, 6 patients)
Pharyngitis (below serious, 1 patient)
Pharyngotonsillitis (below serious, 2 patients)
Anorexia (below serious, 3 patients)
Decreased appetite (below serious, 5 patients)
Arthralgia (below serious, 5 patients)
Muscle spasms (below serious, 1 patient)
Myalgia (below serious, 2 patients)
Pain in extremity (below serious, 3 patients)
Dizziness (below serious, 9 patients)
Headache (below serious, 12 patients)
Hypoaesthesia (below serious, 4 patients)
Lethargy (below serious, 1 patient)
Paraesthesia (below serious, 2 patients)
Sedation (below serious, 3 patients)
Somnolence (below serious, 5 patients)
Tremor (below serious, 2 patients)
Confusional state (below serious, 1 patient)
Insomnia (below serious, 10 patients)
Libido decreased (below serious, 2 patients)
Sleep disorder (below serious, 2 patients)
Nocturia (below serious, 1 patient)
Pollakiuria (below serious, 1 patient)
Erectile dysfunction (below serious, 3 patients)
Pharyngolaryngeal pain (below serious, 2 patients)
Yawning (below serious, 2 patients)
Hot flush (below serious, 5 patients)
Hypertension (below serious, 3 patients)
Sources:
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Other AEs: Acute myocardial infarction, Panic attack...
Other AEs:
Acute myocardial infarction (serious, 1 patient)
Panic attack (serious, 1 patient)
Vision blurred (below serious, 4 patients)
Nausea (below serious, 63 patients)
Dry mouth (below serious, 40 patients)
Diarrhoea (below serious, 19 patients)
Constipation (below serious, 18 patients)
Vomiting (below serious, 5 patients)
Abdominal pain (below serious, 5 patients)
Fatigue (below serious, 13 patients)
Feeling jittery (below serious, 4 patients)
Viral upper respiratory tract infection (below serious, 6 patients)
Accidental overdose (below serious, 2 patients)
Weight decreased (below serious, 4 patients)
Blood pressure increased (below serious, 3 patients)
Decreased appetite (below serious, 8 patients)
Anorexia (below serious, 5 patients)
Headache (below serious, 21 patient)
Dizziness (below serious, 22 patients)
Somnolence (below serious, 20 patients)
Tension headache (below serious, 4 patients)
Tremor (below serious, 4 patients)
Insomnia (below serious, 11 patient)
Restlessness (below serious, 5 patients)
Libido decreased (below serious, 4 patients)
Orgasm abnormal (below serious, 3 patients)
Yawning (below serious, 3 patients)
Hyperhidrosis (below serious, 11 patient)
Sources:
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 154
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 154
Sources:
Other AEs: Angina pectoris, Somnolence...
Other AEs:
Angina pectoris (serious, 1 patient)
Somnolence (serious, 1 patient)
Sexual abuse (serious, 1 patient)
Nausea (below serious, 57 patients)
Dry mouth (below serious, 25 patients)
Constipation (below serious, 8 patients)
Dyspepsia (below serious, 3 patients)
Vomiting (below serious, 10 patients)
Abdominal pain upper (below serious, 2 patients)
Stomach discomfort (below serious, 2 patients)
Fatigue (below serious, 15 patients)
Feeling jittery (below serious, 4 patients)
Influenza (below serious, 2 patients)
Blood creatine phosphokinase increased (below serious, 1 patient)
Decreased appetite (below serious, 11 patient)
Headache (below serious, 26 patients)
Somnolence (below serious, 18 patients)
Dizziness (below serious, 17 patients)
Tension headache (below serious, 2 patients)
Libido decreased (below serious, 7 patients)
Anorgasmia (below serious, 6 patients)
Insomnia (below serious, 6 patients)
Anxiety (below serious, 5 patients)
Abnormal dreams (below serious, 4 patients)
Hyperhidrosis (below serious, 8 patients)
Sources:
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 262
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 262
Sources:
Other AEs: Hernia inguinal, Clostridial infection...
Other AEs:
Hernia inguinal (serious, 1 patient)
Clostridial infection (serious, 1 patient)
Diverticulitis (serious, 1 patient)
Respiratory tract infection (serious, 1 patient)
Syncope (serious, 1 patient)
Suicide attempt (serious, 1 patient)
Vision blurred (below serious, 7 patients)
Abdominal discomfort (below serious, 7 patients)
Constipation (below serious, 17 patients)
Diarrhoea (below serious, 15 patients)
Dry mouth (below serious, 22 patients)
Dyspepsia (below serious, 8 patients)
Nausea (below serious, 51 patient)
Vomiting (below serious, 7 patients)
Fatigue (below serious, 11 patient)
Decreased appetite (below serious, 13 patients)
Dizziness (below serious, 13 patients)
Headache (below serious, 30 patients)
Somnolence (below serious, 24 patients)
Anxiety (below serious, 8 patients)
Insomnia (below serious, 11 patient)
Yawning (below serious, 9 patients)
Hyperhidrosis (below serious, 14 patients)
Sources:
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 261
Health Status: unhealthy
Condition: Depression
Population Size: 261
Sources:
Other AEs: Non-cardiac chest pain, Constipation...
Other AEs:
Non-cardiac chest pain (serious, 1 patient)
Constipation (below serious, 12 patients)
Diarrhoea (below serious, 18 patients)
Dry mouth (below serious, 30 patients)
Nausea (below serious, 46 patients)
Fatigue (below serious, 7 patients)
Decreased appetite (below serious, 10 patients)
Dizziness (below serious, 17 patients)
Somnolence (below serious, 22 patients)
Insomnia (below serious, 14 patients)
Hyperhidrosis (below serious, 8 patients)
Sources:
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 47
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 47
Sources:
Other AEs: Nausea, Diarrhoea...
Other AEs:
Nausea (below serious, 12 patients)
Diarrhoea (below serious, 10 patients)
Dry mouth (below serious, 7 patients)
Upper respiratory tract infection (below serious, 3 patients)
Headache (below serious, 7 patients)
Somnolence (below serious, 5 patients)
Dizziness (below serious, 3 patients)
Insomnia (below serious, 2 patients)
Erectile dysfunction (below serious, 5 patients)
Rash (below serious, 1 patient)
Sources:
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Other AEs: Palpitations, Vision blurred...
Other AEs:
Palpitations (below serious, 5 patients)
Vision blurred (below serious, 6 patients)
Nausea (below serious, 55 patients)
Dry mouth (below serious, 26 patients)
Diarrhoea (below serious, 19 patients)
Constipation (below serious, 18 patients)
Vomiting (below serious, 12 patients)
Dyspepsia (below serious, 7 patients)
Abdominal pain upper (below serious, 4 patients)
Fatigue (below serious, 17 patients)
Feeling jittery (below serious, 5 patients)
Irritability (below serious, 4 patients)
Viral upper respiratory tract infection (below serious, 5 patients)
Urinary tract infection bacterial (below serious, 4 patients)
Muscle strain (below serious, 3 patients)
Decreased appetite (below serious, 15 patients)
Muscle spasms (below serious, 2 patients)
Headache (below serious, 28 patients)
Dizziness (below serious, 24 patients)
Somnolence (below serious, 12 patients)
Dysgeusia (below serious, 5 patients)
Sedation (below serious, 3 patients)
Insomnia (below serious, 14 patients)
Nightmare (below serious, 4 patients)
Restlessness (below serious, 4 patients)
Middle insomnia (below serious, 3 patients)
Nervousness (below serious, 3 patients)
Erectile dysfunction (below serious, 3 patients)
Yawning (below serious, 4 patients)
Rhinorrhoea (below serious, 3 patients)
Hyperhidrosis (below serious, 8 patients)
Hot flush (below serious, 2 patients)
Sources:
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 159
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 159
Sources:
Other AEs: Menopausal symptoms, Metrorrhagia...
Other AEs:
Menopausal symptoms (below serious, 1 patient)
Metrorrhagia (below serious, 1 patient)
Sources:
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Other AEs: Liver disorder, Anaemia...
Other AEs:
Liver disorder (serious, 1 patient)
Anaemia (below serious, 1 patient)
Palpitations (below serious, 5 patients)
Vertigo (below serious, 4 patients)
Vitreous floaters (below serious, 1 patient)
Abdominal discomfort (below serious, 5 patients)
Abdominal distension (below serious, 4 patients)
Abdominal pain (below serious, 1 patient)
Abdominal pain upper (below serious, 6 patients)
Constipation (below serious, 29 patients)
Diarrhoea (below serious, 8 patients)
Dyspepsia (below serious, 2 patients)
Food poisoning (below serious, 1 patient)
Gastritis (below serious, 2 patients)
Nausea (below serious, 42 patients)
Stomatitis (below serious, 4 patients)
Vomiting (below serious, 7 patients)
Asthenia (below serious, 4 patients)
Chest discomfort (below serious, 1 patient)
Fatigue (below serious, 1 patient)
Feeling abnormal (below serious, 2 patients)
Malaise (below serious, 9 patients)
Pyrexia (below serious, 2 patients)
Thirst (below serious, 14 patients)
Hepatic function abnormal (below serious, 5 patients)
Bronchitis (below serious, 2 patients)
Cystitis (below serious, 3 patients)
Folliculitis (below serious, 1 patient)
Hand-foot-and-mouth disease (below serious, 1 patient)
Herpes zoster (below serious, 2 patients)
Hordeolum (below serious, 1 patient)
Influenza (below serious, 3 patients)
Keratitis bacterial (below serious, 1 patient)
Nasopharyngitis (below serious, 26 patients)
Paronychia (below serious, 1 patient)
Pertussis (below serious, 1 patient)
Upper respiratory tract infection (below serious, 2 patients)
Contusion (below serious, 3 patients)
Heat illness (below serious, 1 patient)
Alanine aminotransferase increased (below serious, 2 patients)
Blood alkaline phosphatase increased (below serious, 2 patients)
Blood bilirubin increased (below serious, 5 patients)
Blood cholesterol increased (below serious, 2 patients)
Blood uric acid increased (below serious, 1 patient)
Haematocrit increased (below serious, 1 patient)
Haemoglobin increased (below serious, 1 patient)
Heart rate increased (below serious, 1 patient)
Red blood cell count increased (below serious, 1 patient)
Weight decreased (below serious, 2 patients)
Decreased appetite (below serious, 13 patients)
Arthritis (below serious, 1 patient)
Musculoskeletal stiffness (below serious, 1 patient)
Myalgia (below serious, 1 patient)
Neck mass (below serious, 1 patient)
Nodal osteoarthritis (below serious, 1 patient)
Periarthritis (below serious, 1 patient)
Fasciitis plantar (below serious, 1 patient)
Synovial cyst (below serious, 1 patient)
Tenosynovitis (below serious, 1 patient)
Trigger finger (below serious, 2 patients)
Autonomic nervous system imbalance (below serious, 1 patient)
Dizziness (below serious, 11 patient)
Dizziness postural (below serious, 2 patients)
Dysgeusia (below serious, 1 patient)
Dyskinesia (below serious, 1 patient)
Head discomfort (below serious, 1 patient)
Headache (below serious, 9 patients)
Hypoaesthesia (below serious, 1 patient)
Sensory disturbance (below serious, 1 patient)
Sleep paralysis (below serious, 1 patient)
Somnolence (below serious, 51 patient)
Syncope (below serious, 1 patient)
Tremor (below serious, 1 patient)
Middle insomnia (below serious, 2 patients)
Nightmare (below serious, 1 patient)
Dysuria (below serious, 3 patients)
Hypertonic bladder (below serious, 1 patient)
Pollakiuria (below serious, 2 patients)
Epistaxis (below serious, 1 patient)
Hyperventilation (below serious, 1 patient)
Oropharyngeal discomfort (below serious, 1 patient)
Oropharyngeal pain (below serious, 1 patient)
Allergic rhinitis (below serious, 1 patient)
Yawning (below serious, 1 patient)
Dermatitis atopic (below serious, 1 patient)
Drug eruption (below serious, 1 patient)
Hyperhidrosis (below serious, 2 patients)
Miliaria (below serious, 1 patient)
Pruritus (below serious, 5 patients)
Purpura (below serious, 1 patient)
Rash (below serious, 4 patients)
Rash papular (below serious, 1 patient)
Hot flush (below serious, 1 patient)
Sources:
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 207
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 207
Sources:
Other AEs: Craniocerebral injury, Subdural haematoma...
Other AEs:
Craniocerebral injury (serious, 1 patient)
Subdural haematoma (serious, 1 patient)
Nausea (below serious, 43 patients)
Diarrhoea (below serious, 6 patients)
Dry mouth (below serious, 16 patients)
Decreased appetite (below serious, 12 patients)
Headache (below serious, 24 patients)
Dizziness (below serious, 11 patient)
Sources:
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Other AEs: Benign prostatic hyperplasia...
Other AEs:
Benign prostatic hyperplasia (below serious, 1 patient)
Sources:
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 118
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 118
Sources:
Other AEs: Atrophic vulvovaginitis...
Other AEs:
Atrophic vulvovaginitis (below serious, 1 patient)
Sources:
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Other AEs: Gastric polyps, Intervertebral disc protrusion...
Other AEs:
Gastric polyps (serious, 1 patient)
Intervertebral disc protrusion (serious, 1 patient)
Cerebral haemorrhage (serious, 1 patient)
Calculus urethral (serious, 1 patient)
Idiopathic thrombocytopenic purpura (below serious, 1 patient)
Bundle branch block right (below serious, 1 patient)
Tachycardia (below serious, 2 patients)
Motion sickness (below serious, 1 patient)
Tinnitus (below serious, 2 patients)
Vertigo (below serious, 5 patients)
Vertigo positional (below serious, 1 patient)
Autoimmune thyroiditis (below serious, 1 patient)
Conjunctivitis (below serious, 2 patients)
Conjunctivitis allergic (below serious, 2 patients)
Eye pain (below serious, 1 patient)
Photophobia (below serious, 1 patient)
Abdominal discomfort (below serious, 8 patients)
Abdominal distension (below serious, 3 patients)
Abdominal pain (below serious, 1 patient)
Constipation (below serious, 25 patients)
Dental caries (below serious, 4 patients)
Diarrhoea (below serious, 9 patients)
Dyspepsia (below serious, 4 patients)
Gastritis (below serious, 2 patients)
Atrophic gastritis (below serious, 1 patient)
Gastrointestinal motility disorder (below serious, 1 patient)
Gastrooesophageal reflux disease (below serious, 1 patient)
Infrequent bowel movements (below serious, 1 patient)
Large intestine polyp (below serious, 2 patients)
Nausea (below serious, 21 patient)
Altered saliva (below serious, 1 patient)
Stomatitis (below serious, 2 patients)
Vomiting (below serious, 1 patient)
Face oedema (below serious, 1 patient)
Feeling abnormal (below serious, 2 patients)
Malaise (below serious, 8 patients)
Oedema peripheral (below serious, 1 patient)
Thirst (below serious, 14 patients)
Hepatic function abnormal (below serious, 2 patients)
Bronchitis (below serious, 7 patients)
Gastroenteritis (below serious, 3 patients)
Gingival abscess (below serious, 1 patient)
Gingival infection (below serious, 1 patient)
Pertussis (below serious, 1 patient)
Pharyngitis (below serious, 3 patients)
Bone contusion (below serious, 1 patient)
Chillblains (below serious, 1 patient)
Contusion (below serious, 16 patients)
Excoriation (below serious, 1 patient)
Fall (below serious, 1 patient)
Ligament sprain (below serious, 5 patients)
Nerve root injury cervical (below serious, 2 patients)
Procedural pain (below serious, 4 patients)
Spinal compression fracture (below serious, 1 patient)
Thermal burn (below serious, 1 patient)
Alanine aminotransferase increased (below serious, 4 patients)
Aspartate aminotransferase increased (below serious, 3 patients)
Blood creatine phosphokinase increased (below serious, 4 patients)
Blood lactate dehydrogenase increased (below serious, 1 patient)
Blood urea increased (below serious, 1 patient)
Gamma-glutamyltransferase increased (below serious, 2 patients)
Liver function test abnormal (below serious, 6 patients)
White blood cell count increased (below serious, 1 patient)
Decreased appetite (below serious, 10 patients)
Arthralgia (below serious, 7 patients)
Arthritis (below serious, 2 patients)
Back pain (below serious, 4 patients)
Fasciitis (below serious, 1 patient)
Muscle spasms (below serious, 1 patient)
Trigger finger (below serious, 1 patient)
Carpal tunnel syndrome (below serious, 1 patient)
Dizziness (below serious, 15 patients)
Dizziness postural (below serious, 4 patients)
Dysarthria (below serious, 1 patient)
Headache (below serious, 9 patients)
Hypoaesthesia (below serious, 1 patient)
Migraine (below serious, 2 patients)
Sciatica (below serious, 1 patient)
Somnolence (below serious, 45 patients)
Tension headache (below serious, 1 patient)
Tremor (below serious, 4 patients)
Anxiety (below serious, 1 patient)
Dysphoria (below serious, 1 patient)
Sleep talking (below serious, 1 patient)
Chromaturia (below serious, 1 patient)
Dysuria (below serious, 5 patients)
Haematuria (below serious, 1 patient)
Pollakiuria (below serious, 1 patient)
Urinary retention (below serious, 1 patient)
Urine flow decreased (below serious, 1 patient)
Sexual dysfunction (below serious, 2 patients)
Cough (below serious, 3 patients)
Hyperventilation (below serious, 1 patient)
Oropharyngeal pain (below serious, 1 patient)
Allergic rhinitis (below serious, 2 patients)
Eczema (below serious, 3 patients)
Erythema (below serious, 1 patient)
Hyperhidrosis (below serious, 1 patient)
Pruritus (below serious, 3 patients)
Rash macular (below serious, 1 patient)
Swelling face (below serious, 1 patient)
Hot flush (below serious, 1 patient)
Sources:
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 53
Health Status: unhealthy
Condition: Sub-Acute Pain
Population Size: 53
Sources:
Other AEs: Nausea, Somnolence...
Other AEs:
Nausea (below serious, 2 patients)
Somnolence (below serious, 1 patient)
SIADH (below serious, 1 patient)
Sources:
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 178
Health Status: unhealthy
Condition: Chronic Osteoarthritis
Population Size: 178
Sources:
Other AEs: Malignant ascites, Palpitations...
Other AEs:
Malignant ascites (serious, 1 patient)
Palpitations (below serious, 1 patient)
Ear congestion (below serious, 1 patient)
Tinnitus (below serious, 1 patient)
Vertigo positional (below serious, 1 patient)
Basedow's disease (below serious, 1 patient)
Blepharitis (below serious, 1 patient)
Abdominal distension (below serious, 2 patients)
Abdominal pain upper (below serious, 2 patients)
Anal fissure (below serious, 1 patient)
Cheilitis (below serious, 1 patient)
Constipation (below serious, 19 patients)
Dental caries (below serious, 1 patient)
Diarrhoea (below serious, 6 patients)
Dyspepsia (below serious, 1 patient)
Faeces hard (below serious, 1 patient)
Gastritis (below serious, 3 patients)
Nausea (below serious, 18 patients)
Stomatitis (below serious, 3 patients)
Vomiting (below serious, 3 patients)
Asthenia (below serious, 1 patient)
Malaise (below serious, 12 patients)
Peripheral swelling (below serious, 1 patient)
Thirst (below serious, 19 patients)
Hepatic function abnormal (below serious, 1 patient)
Gingival abscess (below serious, 1 patient)
Gingivitis (below serious, 1 patient)
Hordeolum (below serious, 1 patient)
Oral herpes (below serious, 1 patient)
Paronychia (below serious, 1 patient)
Tonsillitis (below serious, 1 patient)
Chillblains (below serious, 1 patient)
Contusion (below serious, 9 patients)
Excoriation (below serious, 1 patient)
Ligament sprain (below serious, 2 patients)
Limb crushing injury (below serious, 1 patient)
Muscle injury (below serious, 1 patient)
Muscle rupture (below serious, 1 patient)
Procedural pain (below serious, 1 patient)
Alanine aminotransferase increased (below serious, 8 patients)
Aspartate aminotransferase increased (below serious, 7 patients)
Blood potassium decreased (below serious, 1 patient)
Blood urine present (below serious, 3 patients)
Liver function test abnormal (below serious, 1 patient)
Decreased appetite (below serious, 9 patients)
Diabetes mellitus (below serious, 1 patient)
Intervertebral disc protrusion (below serious, 2 patients)
Muscle spasms (below serious, 2 patients)
Osteoporosis (below serious, 1 patient)
Dizziness (below serious, 2 patients)
Dizziness postural (below serious, 1 patient)
Dysgeusia (below serious, 1 patient)
Loss of consciousness (below serious, 1 patient)
Migraine (below serious, 1 patient)
Somnolence (below serious, 24 patients)
Abulia (below serious, 1 patient)
Depression (below serious, 1 patient)
Insomnia (below serious, 3 patients)
Dysuria (below serious, 2 patients)
Hypertonic bladder (below serious, 1 patient)
Stress urinary incontinence (below serious, 1 patient)
Urethral haemorrhage (below serious, 1 patient)
Urinary incontinence (below serious, 1 patient)
Urine flow decreased (below serious, 1 patient)
Cough (below serious, 1 patient)
Upper respiratory tract inflammation (below serious, 3 patients)
Dermatitis (below serious, 1 patient)
Dermatitis contact (below serious, 2 patients)
Eczema (below serious, 1 patient)
Ingrowing nail (below serious, 1 patient)
Dermatitis seborrhoeic (below serious, 1 patient)
Hot flush (below serious, 1 patient)
Hypertension (below serious, 1 patient)
Sources:
AEs

AEs

AESignificanceDosePopulation
Nausea 1.3%
Disc. AE
60 mg 2 times / day multiple, oral (max)
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy, 17 - 89
n = 2327
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: 17 - 89
Sex: M+F
Population Size: 2327
Sources:
Fatigue 1.1%
Disc. AE
60 mg 2 times / day multiple, oral (max)
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy, 17 - 89
n = 568
Health Status: unhealthy
Condition: Diabetic Peripheral Neuropathic Pain
Age Group: 17 - 89
Sex: M+F
Population Size: 568
Sources:
Dizziness 1.6%
Disc. AE
60 mg 2 times / day multiple, oral (max)
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy, 17 - 89
n = 568
Health Status: unhealthy
Condition: Diabetic Peripheral Neuropathic Pain
Age Group: 17 - 89
Sex: M+F
Population Size: 568
Sources:
Somnolence 1.6%
Disc. AE
60 mg 2 times / day multiple, oral (max)
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy, 17 - 89
n = 568
Health Status: unhealthy
Condition: Diabetic Peripheral Neuropathic Pain
Age Group: 17 - 89
Sex: M+F
Population Size: 568
Sources:
Nausea 3.5%
Disc. AE
60 mg 2 times / day multiple, oral (max)
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy, 17 - 89
n = 568
Health Status: unhealthy
Condition: Diabetic Peripheral Neuropathic Pain
Age Group: 17 - 89
Sex: M+F
Population Size: 568
Sources:
Dizziness 1%
Disc. AE
60 mg 2 times / day multiple, oral (max)
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy, 17 - 89
n = 668
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Age Group: 17 - 89
Sex: M+F
Population Size: 668
Sources:
Vomiting 1.3%
Disc. AE
60 mg 2 times / day multiple, oral (max)
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy, 17 - 89
n = 668
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Age Group: 17 - 89
Sex: M+F
Population Size: 668
Sources:
Nausea 3.7%
Disc. AE
60 mg 2 times / day multiple, oral (max)
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy, 17 - 89
n = 668
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Age Group: 17 - 89
Sex: M+F
Population Size: 668
Sources:
Fatigue 1.3%
Disc. AE
60 mg 2 times / day multiple, oral (max)
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy, 17 - 89
n = 876
Health Status: unhealthy
Condition: Fibromyalgia
Age Group: 17 - 89
Sex: M+F
Population Size: 876
Sources:
Somnolence 1.5%
Disc. AE
60 mg 2 times / day multiple, oral (max)
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy, 17 - 89
n = 876
Health Status: unhealthy
Condition: Fibromyalgia
Age Group: 17 - 89
Sex: M+F
Population Size: 876
Sources:
Nausea 1.9%
Disc. AE
60 mg 2 times / day multiple, oral (max)
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy, 17 - 89
n = 876
Health Status: unhealthy
Condition: Fibromyalgia
Age Group: 17 - 89
Sex: M+F
Population Size: 876
Sources:
Anxiety Disc. AE
2820 mg single, oral
Overdose
Dose: 2820 mg
Route: oral
Route: single
Dose: 2820 mg
Sources:
unhealthy, 25
n = 1
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: 25
Sex: M
Population Size: 1
Sources:
Blurred vision Disc. AE
2820 mg single, oral
Overdose
Dose: 2820 mg
Route: oral
Route: single
Dose: 2820 mg
Sources:
unhealthy, 25
n = 1
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: 25
Sex: M
Population Size: 1
Sources:
Generalized tonic-clonic seizure Disc. AE
2820 mg single, oral
Overdose
Dose: 2820 mg
Route: oral
Route: single
Dose: 2820 mg
Sources:
unhealthy, 25
n = 1
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: 25
Sex: M
Population Size: 1
Sources:
Irritability Disc. AE
2820 mg single, oral
Overdose
Dose: 2820 mg
Route: oral
Route: single
Dose: 2820 mg
Sources:
unhealthy, 25
n = 1
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: 25
Sex: M
Population Size: 1
Sources:
Dizziness 3%
Disc. AE
120 mg 1 times / day multiple, oral
Recommended
Dose: 120 mg, 1 times / day
Route: oral
Route: multiple
Dose: 120 mg, 1 times / day
Sources: Page: p.459
unhealthy, 49.9
n = 82
Health Status: unhealthy
Condition: Fibromyalgia
Age Group: 49.9
Sex: M+F
Population Size: 82
Sources: Page: p.459
Pain 3%
Disc. AE
120 mg 1 times / day multiple, oral
Recommended
Dose: 120 mg, 1 times / day
Route: oral
Route: multiple
Dose: 120 mg, 1 times / day
Sources: Page: p.459
unhealthy, 49.9
n = 82
Health Status: unhealthy
Condition: Fibromyalgia
Age Group: 49.9
Sex: M+F
Population Size: 82
Sources: Page: p.459
Fatigue 4%
Disc. AE
120 mg 1 times / day multiple, oral
Recommended
Dose: 120 mg, 1 times / day
Route: oral
Route: multiple
Dose: 120 mg, 1 times / day
Sources: Page: p.458
unhealthy, 51.5
n = 72
Health Status: unhealthy
Condition: Fibromyalgia
Age Group: 51.5
Sex: M+F
Population Size: 72
Sources: Page: p.458
Insomnia 4%
Disc. AE
120 mg 1 times / day multiple, oral
Recommended
Dose: 120 mg, 1 times / day
Route: oral
Route: multiple
Dose: 120 mg, 1 times / day
Sources: Page: p.458
unhealthy, 51.5
n = 72
Health Status: unhealthy
Condition: Fibromyalgia
Age Group: 51.5
Sex: M+F
Population Size: 72
Sources: Page: p.458
Libido decreased below serious, 1 patient
4 mg single, oral
Dose: 4 mg
Route: oral
Route: single
Dose: 4 mg
Sources:
healthy, adult
n = 83
Health Status: healthy
Age Group: adult
Sex: M
Population Size: 83
Sources:
Fatigue below serious, 2 patients
4 mg single, oral
Dose: 4 mg
Route: oral
Route: single
Dose: 4 mg
Sources:
healthy, adult
n = 83
Health Status: healthy
Age Group: adult
Sex: M
Population Size: 83
Sources:
Nausea below serious, 2 patients
4 mg single, oral
Dose: 4 mg
Route: oral
Route: single
Dose: 4 mg
Sources:
healthy, adult
n = 83
Health Status: healthy
Age Group: adult
Sex: M
Population Size: 83
Sources:
Stomach discomfort below serious, 4 patients
4 mg single, oral
Dose: 4 mg
Route: oral
Route: single
Dose: 4 mg
Sources:
healthy, adult
n = 83
Health Status: healthy
Age Group: adult
Sex: M
Population Size: 83
Sources:
Decreased appetite below serious, 10 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy, children|adolescents
n = 117
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: children|adolescents
Population Size: 117
Sources:
Dizziness below serious, 10 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy, children|adolescents
n = 117
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: children|adolescents
Population Size: 117
Sources:
Headache below serious, 19 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy, children|adolescents
n = 117
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: children|adolescents
Population Size: 117
Sources:
Nausea below serious, 20 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy, children|adolescents
n = 117
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: children|adolescents
Population Size: 117
Sources:
Upper respiratory tract infection below serious, 4 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy, children|adolescents
n = 117
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: children|adolescents
Population Size: 117
Sources:
Diarrhoea below serious, 6 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy, children|adolescents
n = 117
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: children|adolescents
Population Size: 117
Sources:
Insomnia below serious, 6 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy, children|adolescents
n = 117
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: children|adolescents
Population Size: 117
Sources:
Influenza below serious, 7 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy, children|adolescents
n = 117
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: children|adolescents
Population Size: 117
Sources:
Somnolence below serious, 7 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy, children|adolescents
n = 117
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: children|adolescents
Population Size: 117
Sources:
Vomiting below serious, 7 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy, children|adolescents
n = 117
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: children|adolescents
Population Size: 117
Sources:
Fatigue below serious, 8 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy, children|adolescents
n = 117
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: children|adolescents
Population Size: 117
Sources:
Drug abuse serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy, children|adolescents
n = 117
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: children|adolescents
Population Size: 117
Sources:
Panic attack serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy, children|adolescents
n = 117
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: children|adolescents
Population Size: 117
Sources:
Social phobia serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy, children|adolescents
n = 117
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: children|adolescents
Population Size: 117
Sources:
Syncope serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy, children|adolescents
n = 117
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: children|adolescents
Population Size: 117
Sources:
Diarrhoea below serious, 14 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy, elderly
n = 151
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: elderly
Population Size: 151
Sources:
Dizziness below serious, 14 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy, elderly
n = 151
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: elderly
Population Size: 151
Sources:
Fatigue below serious, 16 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy, elderly
n = 151
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: elderly
Population Size: 151
Sources:
Hyperhidrosis below serious, 16 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy, elderly
n = 151
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: elderly
Population Size: 151
Sources:
Somnolence below serious, 16 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy, elderly
n = 151
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: elderly
Population Size: 151
Sources:
Constipation below serious, 21 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy, elderly
n = 151
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: elderly
Population Size: 151
Sources:
Dry mouth below serious, 33 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy, elderly
n = 151
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: elderly
Population Size: 151
Sources:
Nausea below serious, 50 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy, elderly
n = 151
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: elderly
Population Size: 151
Sources:
Decreased appetite below serious, 8 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy, elderly
n = 151
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: elderly
Population Size: 151
Sources:
Ejaculation delayed below serious, 3 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy, elderly
n = 51
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: elderly
Population Size: 51
Sources:
Erectile dysfunction below serious, 3 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy, elderly
n = 51
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: elderly
Population Size: 51
Sources:
Prostate cancer serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy, elderly
n = 51
Health Status: unhealthy
Condition: Major Depressive Disorder
Age Group: elderly
Population Size: 51
Sources:
Bleeding Disc. AE
60 mg 2 times / day multiple, oral
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy
Health Status: unhealthy
Condition: Major Depressive Disorder|Generalized Anxiety Disorder
Sources:
Hepatic failure Disc. AE
60 mg 2 times / day multiple, oral
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy
Health Status: unhealthy
Condition: Major Depressive Disorder|Generalized Anxiety Disorder
Sources:
Hypomania Disc. AE
60 mg 2 times / day multiple, oral
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy
Health Status: unhealthy
Condition: Major Depressive Disorder|Generalized Anxiety Disorder
Sources:
Hyponatremia Disc. AE
60 mg 2 times / day multiple, oral
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy
Health Status: unhealthy
Condition: Major Depressive Disorder|Generalized Anxiety Disorder
Sources:
Mania Disc. AE
60 mg 2 times / day multiple, oral
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy
Health Status: unhealthy
Condition: Major Depressive Disorder|Generalized Anxiety Disorder
Sources:
Neuroleptic malignant syndrome Disc. AE
60 mg 2 times / day multiple, oral
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy
Health Status: unhealthy
Condition: Major Depressive Disorder|Generalized Anxiety Disorder
Sources:
Orthostatic hypotension Disc. AE
60 mg 2 times / day multiple, oral
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy
Health Status: unhealthy
Condition: Major Depressive Disorder|Generalized Anxiety Disorder
Sources:
Seizures Disc. AE
60 mg 2 times / day multiple, oral
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy
Health Status: unhealthy
Condition: Major Depressive Disorder|Generalized Anxiety Disorder
Sources:
Serotonin syndrome Disc. AE
60 mg 2 times / day multiple, oral
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy
Health Status: unhealthy
Condition: Major Depressive Disorder|Generalized Anxiety Disorder
Sources:
Suicidal behavior Disc. AE
60 mg 2 times / day multiple, oral
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy
Health Status: unhealthy
Condition: Major Depressive Disorder|Generalized Anxiety Disorder
Sources:
Suicidal ideation Disc. AE
60 mg 2 times / day multiple, oral
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy
Health Status: unhealthy
Condition: Major Depressive Disorder|Generalized Anxiety Disorder
Sources:
Syncope Disc. AE
60 mg 2 times / day multiple, oral
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy
Health Status: unhealthy
Condition: Major Depressive Disorder|Generalized Anxiety Disorder
Sources:
Urinary hesitation Disc. AE
60 mg 2 times / day multiple, oral
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy
Health Status: unhealthy
Condition: Major Depressive Disorder|Generalized Anxiety Disorder
Sources:
Urinary retention Disc. AE
60 mg 2 times / day multiple, oral
Recommended
Dose: 60 mg, 2 times / day
Route: oral
Route: multiple
Dose: 60 mg, 2 times / day
Sources:
unhealthy
Health Status: unhealthy
Condition: Major Depressive Disorder|Generalized Anxiety Disorder
Sources:
Abdominal pain below serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Hot flush below serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Hyperglycaemia below serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Hypersomnia below serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Hypoaesthesia below serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Muscle spasms below serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Therapeutic response unexpected below serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Yawning below serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Fatigue below serious, 10 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Headache below serious, 10 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Dry mouth below serious, 12 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Constipation below serious, 14 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Nausea below serious, 14 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Somnolence below serious, 14 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Abdominal distension below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Abdominal pain upper below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Ejaculation delayed below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Ejaculation disorder below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Gastrooesophageal reflux disease below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Hypokalaemia below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Irritability below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Lethargy below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Loss of libido below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Musculoskeletal pain below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Pain in extremity below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Paraesthesia below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Pharyngolaryngeal pain below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Pollakiuria below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Stomach discomfort below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Testicular pain below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Urinary tract infection below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Vision blurred below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Insomnia below serious, 21 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Anorexia below serious, 3 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Anorgasmia below serious, 3 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Asthenia below serious, 3 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Dyspepsia below serious, 3 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Erectile dysfunction below serious, 3 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Palpitations below serious, 3 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Pruritus below serious, 3 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Sedation below serious, 3 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Vomiting below serious, 3 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Libido decreased below serious, 4 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Nocturia below serious, 4 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Sleep disorder below serious, 4 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Decreased appetite below serious, 5 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Hyperhidrosis below serious, 5 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Hypertension below serious, 5 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Diarrhoea below serious, 7 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Dizziness below serious, 9 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Diarrhoea serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Hypoaesthesia oral serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Hypoaesthesia serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Myocardial infarction serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Transient ischaemic attack serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 112
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 112
Sources:
Dry mouth below serious, 11 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Nausea below serious, 14 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Abdominal pain upper below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Anorexia below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Asthenia below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Dysgeusia below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Dyspepsia below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Sinusitis below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Vomiting below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Weight increased below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Abdominal distension below serious, 3 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Erectile dysfunction below serious, 3 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Migraine below serious, 3 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Neck pain below serious, 3 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Tachycardia below serious, 3 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Vertigo below serious, 3 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Influenza below serious, 4 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Constipation below serious, 6 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Somnolence below serious, 6 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Dizziness below serious, 7 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Diarrhoea below serious, 8 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Fatigue below serious, 8 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Hyperhidrosis below serious, 8 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Encephalopathy hypertensive serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Transient ischaemic attack serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Wrist fracture serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Osteoarthritis serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 115
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 115
Sources:
Constipation below serious, 5 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 20
Health Status: unhealthy
Condition: Depression
Population Size: 20
Sources:
Hyperhidrosis below serious, 5 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 20
Health Status: unhealthy
Condition: Depression
Population Size: 20
Sources:
Dry mouth below serious, 7 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 20
Health Status: unhealthy
Condition: Depression
Population Size: 20
Sources:
Nausea below serious, 9 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 20
Health Status: unhealthy
Condition: Depression
Population Size: 20
Sources:
Gastrointestinal disorder (NOS) serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 20
Health Status: unhealthy
Condition: Depression
Population Size: 20
Sources:
Sinus infection serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 20
Health Status: unhealthy
Condition: Depression
Population Size: 20
Sources:
Vomiting below serious, 12 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 263
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 263
Sources:
Decreased appetite below serious, 13 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 263
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 263
Sources:
Hot flush below serious, 13 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 263
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 263
Sources:
Somnolence below serious, 15 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 263
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 263
Sources:
Hyperhidrosis below serious, 23 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 263
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 263
Sources:
Insomnia below serious, 24 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 263
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 263
Sources:
Fatigue below serious, 25 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 263
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 263
Sources:
Dizziness below serious, 26 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 263
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 263
Sources:
Diarrhoea below serious, 27 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 263
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 263
Sources:
Dry mouth below serious, 31 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 263
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 263
Sources:
Constipation below serious, 35 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 263
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 263
Sources:
Headache below serious, 45 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 263
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 263
Sources:
Nausea below serious, 83 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 263
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 263
Sources:
Intervertebral disc protrusion serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 263
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 263
Sources:
Dizziness below serious, 10 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Somnolence below serious, 10 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Constipation below serious, 12 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Dry mouth below serious, 13 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Asthenia below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Confusional state below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Decreased appetite below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Ejaculation disorder below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Hypertransaminasaemia below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Increased appetite below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Joint sprain below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Migraine below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Muscle spasms below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Neck pain below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Pruritus below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Sexual dysfunction below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Tinnitus below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Toothache below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Urinary retention below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Urine flow decreased below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Viral infection below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Vision blurred below serious, 2 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Headache below serious, 27 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Flatulence below serious, 3 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Nausea below serious, 35 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Anorexia below serious, 4 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Libido decreased below serious, 4 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Yawning below serious, 4 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Hyperhidrosis below serious, 5 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Nasopharyngitis below serious, 5 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Vertigo below serious, 5 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Fatigue below serious, 7 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Diarrhoea below serious, 9 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Acute myocardial infarction serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Alcohol poisoning serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Asthma serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Myopathy toxic serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Vertigo serious, 1 patient
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 198
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 198
Sources:
Constipation below serious, 10 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 108
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 108
Sources:
Dry mouth below serious, 10 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 108
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 108
Sources:
Somnolence below serious, 12 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 108
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 108
Sources:
Dizziness below serious, 15 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 108
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 108
Sources:
Decreased appetite below serious, 3 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 108
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 108
Sources:
Palpitations below serious, 3 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 108
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 108
Sources:
Vision blurred below serious, 3 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 108
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 108
Sources:
Nausea below serious, 30 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 108
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 108
Sources:
Fatigue below serious, 4 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 108
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 108
Sources:
Tremor below serious, 4 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 108
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 108
Sources:
Asthenia below serious, 5 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 108
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 108
Sources:
Anorexia below serious, 6 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 108
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 108
Sources:
Vomiting below serious, 6 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 108
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 108
Sources:
Abdominal discomfort below serious, 7 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 108
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 108
Sources:
Hyperhidrosis below serious, 7 patients
120 mg 1 times / day steady, oral (max)
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 108
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 108
Sources:
Hyperhidrosis below serious, 10 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Vomiting below serious, 11 patient
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Insomnia below serious, 13 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Somnolence below serious, 14 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Decreased appetite below serious, 15 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Headache below serious, 16 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Dizziness below serious, 17 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Diarrhoea below serious, 18 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Fatigue below serious, 18 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Constipation below serious, 23 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Dry mouth below serious, 25 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Dermatitis contact below serious, 3 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Dyspepsia below serious, 3 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Dysuria below serious, 3 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Feeling jittery below serious, 3 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Hypertension below serious, 3 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Liver function test abnormal below serious, 3 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Rash below serious, 3 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Thirst below serious, 3 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Tremor below serious, 3 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Urine flow decreased below serious, 3 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Weight increased below serious, 3 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Abdominal pain below serious, 4 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Dysgeusia below serious, 4 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Hot flush below serious, 4 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Night sweats below serious, 4 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Palpitations below serious, 4 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Nausea below serious, 41 patient
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Abdominal discomfort below serious, 5 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Erectile dysfunction below serious, 5 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Libido decreased below serious, 5 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Vision blurred below serious, 5 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Arthralgia below serious, 6 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Cough below serious, 6 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Flatulence below serious, 6 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Pollakiuria below serious, 6 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Abdominal pain upper below serious, 7 patients
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Coronary artery disease serious, 1 patient
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Fall serious, 1 patient
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Metastases to central nervous system serious, 1 patient
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Syncope serious, 1 patient
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Urosepsis serious, 1 patient
120 mg 1 times / day steady, oral
Dose: 120 mg, 1 times / day
Route: oral
Route: steady
Dose: 120 mg, 1 times / day
Sources:
unhealthy
n = 264
Health Status: unhealthy
Condition: Osteoarthritis
Population Size: 264
Sources:
Abdominal pain below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Acne below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Anorexia below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Aphonia below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Back pain below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Breast cyst below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Cardiac ablation below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Colonic polyp below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Confusional state below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Cystitis below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Dehydration below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Drug hypersensitivity below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Dysphoria below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Epistaxis below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Erectile dysfunction below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Folliculitis below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Gastritis below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Gastroenteritis below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Generalised pruritus below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Groin pain below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Haemarthrosis below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Haemorrhage vaginal below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Hyperglycaemia below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Hypersomnia below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Joint injury below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Kidney infection below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Muscle spasms below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Muscle strain below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Musculoskeletal pain below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Myalgia below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Nasal congestion below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Neurological examination abnormal below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Non-cardiac chest pain below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Osteoarthritis below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Psoriasis below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Stomach discomfort below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Therapeutic response unexpected below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Tooth abscess below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Vision blurred below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Vulvovaginal pruritus below serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Nausea below serious, 11 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Arthralgia below serious, 2 patients
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Asthma below serious, 2 patients
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Conjunctivitis below serious, 2 patients
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Constipation below serious, 2 patients
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Irritability below serious, 2 patients
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Libido decreased below serious, 2 patients
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Urinary tract infection below serious, 2 patients
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Vomiting below serious, 2 patients
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Dizziness below serious, 3 patients
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Dry mouth below serious, 3 patients
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Somnolence below serious, 3 patients
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Pharyngitis below serious, 4 patients
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Insomnia below serious, 6 patients
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Non-cardiac chest pain serious, 1 patient
20 mg 1 times / day steady, oral
Dose: 20 mg, 1 times / day
Route: oral
Route: steady
Dose: 20 mg, 1 times / day
Sources:
unhealthy
n = 59
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 59
Sources:
Pain in extremity below serious, 10 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Contusion below serious, 12 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Upper respiratory tract infection below serious, 13 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Fatigue below serious, 14 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Hyperhidrosis below serious, 15 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Dizziness below serious, 26 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Nausea below serious, 28 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Diarrhoea below serious, 31 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Headache below serious, 32 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Dry mouth below serious, 34 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Constipation below serious, 37 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Orthostatic hypotension below serious, 5 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Fall below serious, 59 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Abscess intestinal serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Ankle fracture serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Arrhythmia serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Atrial flutter serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Coronary artery occlusion serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Diabetes mellitus serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Dyspnoea serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Head injury serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Hip fracture serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Interstitial lung disease serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Intracranial aneurysm serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Oesophageal adenocarcinoma metastatic serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Orthostatic hypotension serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Osteoarthritis spinal serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Pneumoperitoneum serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Prostatitis serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Renal failure acute serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Chest pain serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 249
Health Status: unhealthy
Condition: Depression
Population Size: 249
Sources:
Confusional state below serious, 1 patient
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Lethargy below serious, 1 patient
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Muscle spasms below serious, 1 patient
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Nocturia below serious, 1 patient
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Pharyngitis below serious, 1 patient
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Pollakiuria below serious, 1 patient
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Vision blurred below serious, 1 patient
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Constipation below serious, 10 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Diarrhoea below serious, 10 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Insomnia below serious, 10 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Dry mouth below serious, 12 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Headache below serious, 12 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Abdominal pain below serious, 2 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Feeling abnormal below serious, 2 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Libido decreased below serious, 2 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Myalgia below serious, 2 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Paraesthesia below serious, 2 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Pharyngolaryngeal pain below serious, 2 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Pharyngotonsillitis below serious, 2 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Sleep disorder below serious, 2 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Tremor below serious, 2 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Vomiting below serious, 2 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Yawning below serious, 2 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Nausea below serious, 24 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Anorexia below serious, 3 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Dyspepsia below serious, 3 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Erectile dysfunction below serious, 3 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Gastroenteritis below serious, 3 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Hypertension below serious, 3 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Pain in extremity below serious, 3 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Palpitations below serious, 3 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Sedation below serious, 3 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Hypoaesthesia below serious, 4 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Arthralgia below serious, 5 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Decreased appetite below serious, 5 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Hot flush below serious, 5 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Somnolence below serious, 5 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Influenza below serious, 6 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Fatigue below serious, 7 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Dizziness below serious, 9 patients
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Dizziness serious, 1 patient
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Dyspnoea serious, 1 patient
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Muscular weakness serious, 1 patient
60 mg 1 times / day steady, oral (max)
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Hyperhidrosis below serious, 11 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Insomnia below serious, 11 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Fatigue below serious, 13 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Constipation below serious, 18 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Diarrhoea below serious, 19 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Accidental overdose below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Somnolence below serious, 20 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Headache below serious, 21 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Dizziness below serious, 22 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Blood pressure increased below serious, 3 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Orgasm abnormal below serious, 3 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Yawning below serious, 3 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Feeling jittery below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Libido decreased below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Tension headache below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Tremor below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Vision blurred below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Weight decreased below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Dry mouth below serious, 40 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Abdominal pain below serious, 5 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Anorexia below serious, 5 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Restlessness below serious, 5 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Vomiting below serious, 5 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Viral upper respiratory tract infection below serious, 6 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Nausea below serious, 63 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Decreased appetite below serious, 8 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Acute myocardial infarction serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Panic attack serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Blood creatine phosphokinase increased below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 154
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 154
Sources:
Vomiting below serious, 10 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 154
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 154
Sources:
Decreased appetite below serious, 11 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 154
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 154
Sources:
Fatigue below serious, 15 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 154
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 154
Sources:
Dizziness below serious, 17 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 154
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 154
Sources:
Somnolence below serious, 18 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 154
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 154
Sources:
Abdominal pain upper below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 154
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 154
Sources:
Influenza below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 154
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 154
Sources:
Stomach discomfort below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 154
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 154
Sources:
Tension headache below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 154
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 154
Sources:
Dry mouth below serious, 25 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 154
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 154
Sources:
Headache below serious, 26 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 154
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 154
Sources:
Dyspepsia below serious, 3 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 154
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 154
Sources:
Abnormal dreams below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 154
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 154
Sources:
Feeling jittery below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 154
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 154
Sources:
Anxiety below serious, 5 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 154
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 154
Sources:
Nausea below serious, 57 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 154
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 154
Sources:
Anorgasmia below serious, 6 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 154
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 154
Sources:
Insomnia below serious, 6 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 154
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 154
Sources:
Libido decreased below serious, 7 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 154
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 154
Sources:
Constipation below serious, 8 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 154
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 154
Sources:
Hyperhidrosis below serious, 8 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 154
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 154
Sources:
Angina pectoris serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 154
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 154
Sources:
Sexual abuse serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 154
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 154
Sources:
Somnolence serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 154
Health Status: unhealthy
Condition: Generalized Anxiety Disorder
Population Size: 154
Sources:
Fatigue below serious, 11 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 262
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 262
Sources:
Insomnia below serious, 11 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 262
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 262
Sources:
Decreased appetite below serious, 13 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 262
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 262
Sources:
Dizziness below serious, 13 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 262
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 262
Sources:
Hyperhidrosis below serious, 14 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 262
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 262
Sources:
Diarrhoea below serious, 15 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 262
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 262
Sources:
Constipation below serious, 17 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 262
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 262
Sources:
Dry mouth below serious, 22 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 262
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 262
Sources:
Somnolence below serious, 24 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 262
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 262
Sources:
Headache below serious, 30 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 262
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 262
Sources:
Nausea below serious, 51 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 262
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 262
Sources:
Abdominal discomfort below serious, 7 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 262
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 262
Sources:
Vision blurred below serious, 7 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 262
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 262
Sources:
Vomiting below serious, 7 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 262
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 262
Sources:
Anxiety below serious, 8 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 262
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 262
Sources:
Dyspepsia below serious, 8 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 262
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 262
Sources:
Yawning below serious, 9 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 262
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 262
Sources:
Clostridial infection serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 262
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 262
Sources:
Diverticulitis serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 262
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 262
Sources:
Hernia inguinal serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 262
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 262
Sources:
Respiratory tract infection serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 262
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 262
Sources:
Suicide attempt serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 262
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 262
Sources:
Syncope serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 262
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 262
Sources:
Decreased appetite below serious, 10 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 261
Health Status: unhealthy
Condition: Depression
Population Size: 261
Sources:
Constipation below serious, 12 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 261
Health Status: unhealthy
Condition: Depression
Population Size: 261
Sources:
Insomnia below serious, 14 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 261
Health Status: unhealthy
Condition: Depression
Population Size: 261
Sources:
Dizziness below serious, 17 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 261
Health Status: unhealthy
Condition: Depression
Population Size: 261
Sources:
Diarrhoea below serious, 18 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 261
Health Status: unhealthy
Condition: Depression
Population Size: 261
Sources:
Somnolence below serious, 22 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 261
Health Status: unhealthy
Condition: Depression
Population Size: 261
Sources:
Dry mouth below serious, 30 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 261
Health Status: unhealthy
Condition: Depression
Population Size: 261
Sources:
Nausea below serious, 46 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 261
Health Status: unhealthy
Condition: Depression
Population Size: 261
Sources:
Fatigue below serious, 7 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 261
Health Status: unhealthy
Condition: Depression
Population Size: 261
Sources:
Hyperhidrosis below serious, 8 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 261
Health Status: unhealthy
Condition: Depression
Population Size: 261
Sources:
Non-cardiac chest pain serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 261
Health Status: unhealthy
Condition: Depression
Population Size: 261
Sources:
Rash below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 47
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 47
Sources:
Diarrhoea below serious, 10 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 47
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 47
Sources:
Nausea below serious, 12 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 47
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 47
Sources:
Insomnia below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 47
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 47
Sources:
Dizziness below serious, 3 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 47
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 47
Sources:
Upper respiratory tract infection below serious, 3 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 47
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 47
Sources:
Erectile dysfunction below serious, 5 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 47
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 47
Sources:
Somnolence below serious, 5 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 47
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 47
Sources:
Dry mouth below serious, 7 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 47
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 47
Sources:
Headache below serious, 7 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 47
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 47
Sources:
Somnolence below serious, 12 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Vomiting below serious, 12 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Insomnia below serious, 14 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Decreased appetite below serious, 15 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Fatigue below serious, 17 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Constipation below serious, 18 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Diarrhoea below serious, 19 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Hot flush below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Muscle spasms below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Dizziness below serious, 24 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Dry mouth below serious, 26 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Headache below serious, 28 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Erectile dysfunction below serious, 3 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Middle insomnia below serious, 3 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Muscle strain below serious, 3 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Nervousness below serious, 3 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Rhinorrhoea below serious, 3 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Sedation below serious, 3 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Abdominal pain upper below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Irritability below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Nightmare below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Restlessness below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Urinary tract infection bacterial below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Yawning below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Dysgeusia below serious, 5 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Feeling jittery below serious, 5 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Palpitations below serious, 5 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Viral upper respiratory tract infection below serious, 5 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Nausea below serious, 55 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Vision blurred below serious, 6 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Dyspepsia below serious, 7 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Hyperhidrosis below serious, 8 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 150
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 150
Sources:
Menopausal symptoms below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 159
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 159
Sources:
Metrorrhagia below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 159
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 159
Sources:
Abdominal pain below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Allergic rhinitis below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Anaemia below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Arthritis below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Autonomic nervous system imbalance below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Blood uric acid increased below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Chest discomfort below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Dermatitis atopic below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Drug eruption below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Dysgeusia below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Dyskinesia below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Epistaxis below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Fasciitis plantar below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Fatigue below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Folliculitis below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Food poisoning below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Haematocrit increased below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Haemoglobin increased below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Hand-foot-and-mouth disease below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Head discomfort below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Heart rate increased below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Heat illness below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Hordeolum below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Hot flush below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Hypertonic bladder below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Hyperventilation below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Hypoaesthesia below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Keratitis bacterial below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Miliaria below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Musculoskeletal stiffness below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Myalgia below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Neck mass below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Nightmare below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Nodal osteoarthritis below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Oropharyngeal discomfort below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Oropharyngeal pain below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Paronychia below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Periarthritis below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Pertussis below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Purpura below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Rash papular below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Red blood cell count increased below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Sensory disturbance below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Sleep paralysis below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Syncope below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Synovial cyst below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Tenosynovitis below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Tremor below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Vitreous floaters below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Yawning below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Dizziness below serious, 11 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Decreased appetite below serious, 13 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Thirst below serious, 14 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Alanine aminotransferase increased below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Blood alkaline phosphatase increased below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Blood cholesterol increased below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Bronchitis below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Dizziness postural below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Dyspepsia below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Feeling abnormal below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Gastritis below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Herpes zoster below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Hyperhidrosis below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Middle insomnia below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Pollakiuria below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Pyrexia below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Trigger finger below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Upper respiratory tract infection below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Weight decreased below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Nasopharyngitis below serious, 26 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Constipation below serious, 29 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Contusion below serious, 3 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Cystitis below serious, 3 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Dysuria below serious, 3 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Influenza below serious, 3 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Abdominal distension below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Asthenia below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Rash below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Stomatitis below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Vertigo below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Nausea below serious, 42 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Abdominal discomfort below serious, 5 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Blood bilirubin increased below serious, 5 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Hepatic function abnormal below serious, 5 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Palpitations below serious, 5 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Pruritus below serious, 5 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Somnolence below serious, 51 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Abdominal pain upper below serious, 6 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Vomiting below serious, 7 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Diarrhoea below serious, 8 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Headache below serious, 9 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Malaise below serious, 9 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Liver disorder serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 194
Health Status: unhealthy
Condition: Fibromyalgia
Population Size: 194
Sources:
Dizziness below serious, 11 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 207
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 207
Sources:
Decreased appetite below serious, 12 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 207
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 207
Sources:
Dry mouth below serious, 16 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 207
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 207
Sources:
Headache below serious, 24 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 207
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 207
Sources:
Nausea below serious, 43 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 207
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 207
Sources:
Diarrhoea below serious, 6 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 207
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 207
Sources:
Craniocerebral injury serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 207
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 207
Sources:
Subdural haematoma serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 207
Health Status: unhealthy
Condition: Major Depressive Disorder
Population Size: 207
Sources:
Benign prostatic hyperplasia below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 116
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 116
Sources:
Atrophic vulvovaginitis below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 118
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 118
Sources:
Abdominal pain below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Altered saliva below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Anxiety below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Atrophic gastritis below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Autoimmune thyroiditis below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Blood lactate dehydrogenase increased below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Blood urea increased below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Bone contusion below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Bundle branch block right below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Carpal tunnel syndrome below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Chillblains below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Chromaturia below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Dysarthria below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Dysphoria below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Erythema below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Excoriation below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Eye pain below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Face oedema below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Fall below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Fasciitis below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Gastrointestinal motility disorder below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Gastrooesophageal reflux disease below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Gingival abscess below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Gingival infection below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Haematuria below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Hot flush below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Hyperhidrosis below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Hyperventilation below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Hypoaesthesia below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Idiopathic thrombocytopenic purpura below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Infrequent bowel movements below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Motion sickness below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Muscle spasms below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Oedema peripheral below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Oropharyngeal pain below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Pertussis below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Photophobia below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Pollakiuria below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Rash macular below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Sciatica below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Sleep talking below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Spinal compression fracture below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Swelling face below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Tension headache below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Thermal burn below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Trigger finger below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Urinary retention below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Urine flow decreased below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Vertigo positional below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Vomiting below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
White blood cell count increased below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Decreased appetite below serious, 10 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Thirst below serious, 14 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Dizziness below serious, 15 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Contusion below serious, 16 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Allergic rhinitis below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Arthritis below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Conjunctivitis allergic below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Conjunctivitis below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Feeling abnormal below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Gamma-glutamyltransferase increased below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Gastritis below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Hepatic function abnormal below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Large intestine polyp below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Migraine below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Nerve root injury cervical below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Sexual dysfunction below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Stomatitis below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Tachycardia below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Tinnitus below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Nausea below serious, 21 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Constipation below serious, 25 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Abdominal distension below serious, 3 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Aspartate aminotransferase increased below serious, 3 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Cough below serious, 3 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Eczema below serious, 3 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Gastroenteritis below serious, 3 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Pharyngitis below serious, 3 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Pruritus below serious, 3 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Alanine aminotransferase increased below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Back pain below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Blood creatine phosphokinase increased below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Dental caries below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Dizziness postural below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Dyspepsia below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Procedural pain below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Tremor below serious, 4 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Somnolence below serious, 45 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Dysuria below serious, 5 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Ligament sprain below serious, 5 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Vertigo below serious, 5 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Liver function test abnormal below serious, 6 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Arthralgia below serious, 7 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Bronchitis below serious, 7 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Abdominal discomfort below serious, 8 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Malaise below serious, 8 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Diarrhoea below serious, 9 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Headache below serious, 9 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Calculus urethral serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Cerebral haemorrhage serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Gastric polyps serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
Intervertebral disc protrusion serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 234
Health Status: unhealthy
Condition: Chronic Low Back Pain
Population Size: 234
Sources:
SIADH below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 53
Health Status: unhealthy
Condition: Sub-Acute Pain
Population Size: 53
Sources:
Somnolence below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 53
Health Status: unhealthy
Condition: Sub-Acute Pain
Population Size: 53
Sources:
Nausea below serious, 2 patients
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 53
Health Status: unhealthy
Condition: Sub-Acute Pain
Population Size: 53
Sources:
Abulia below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 178
Health Status: unhealthy
Condition: Chronic Osteoarthritis
Population Size: 178
Sources:
Anal fissure below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 178
Health Status: unhealthy
Condition: Chronic Osteoarthritis
Population Size: 178
Sources:
Asthenia below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 178
Health Status: unhealthy
Condition: Chronic Osteoarthritis
Population Size: 178
Sources:
Basedow's disease below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 178
Health Status: unhealthy
Condition: Chronic Osteoarthritis
Population Size: 178
Sources:
Blepharitis below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 178
Health Status: unhealthy
Condition: Chronic Osteoarthritis
Population Size: 178
Sources:
Blood potassium decreased below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 178
Health Status: unhealthy
Condition: Chronic Osteoarthritis
Population Size: 178
Sources:
Cheilitis below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 178
Health Status: unhealthy
Condition: Chronic Osteoarthritis
Population Size: 178
Sources:
Chillblains below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 178
Health Status: unhealthy
Condition: Chronic Osteoarthritis
Population Size: 178
Sources:
Cough below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 178
Health Status: unhealthy
Condition: Chronic Osteoarthritis
Population Size: 178
Sources:
Dental caries below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 178
Health Status: unhealthy
Condition: Chronic Osteoarthritis
Population Size: 178
Sources:
Depression below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 178
Health Status: unhealthy
Condition: Chronic Osteoarthritis
Population Size: 178
Sources:
Dermatitis seborrhoeic below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 178
Health Status: unhealthy
Condition: Chronic Osteoarthritis
Population Size: 178
Sources:
Dermatitis below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 178
Health Status: unhealthy
Condition: Chronic Osteoarthritis
Population Size: 178
Sources:
Diabetes mellitus below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 178
Health Status: unhealthy
Condition: Chronic Osteoarthritis
Population Size: 178
Sources:
Dizziness postural below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 178
Health Status: unhealthy
Condition: Chronic Osteoarthritis
Population Size: 178
Sources:
Dysgeusia below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 178
Health Status: unhealthy
Condition: Chronic Osteoarthritis
Population Size: 178
Sources:
Dyspepsia below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 178
Health Status: unhealthy
Condition: Chronic Osteoarthritis
Population Size: 178
Sources:
Ear congestion below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 178
Health Status: unhealthy
Condition: Chronic Osteoarthritis
Population Size: 178
Sources:
Eczema below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 178
Health Status: unhealthy
Condition: Chronic Osteoarthritis
Population Size: 178
Sources:
Excoriation below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 178
Health Status: unhealthy
Condition: Chronic Osteoarthritis
Population Size: 178
Sources:
Faeces hard below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 178
Health Status: unhealthy
Condition: Chronic Osteoarthritis
Population Size: 178
Sources:
Gingival abscess below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 178
Health Status: unhealthy
Condition: Chronic Osteoarthritis
Population Size: 178
Sources:
Gingivitis below serious, 1 patient
60 mg 1 times / day steady, oral
Dose: 60 mg, 1 times / day
Route: oral
Route: steady
Dose: 60 mg, 1 times / day
Sources:
unhealthy
n = 178
Health Status: